Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
16.28
-0.76 (-4.46%)
Nov 12, 2026, 4:00 PM EST - Market closed
Aktis Oncology Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $35 | Buy | Maintains | $35 | +114.99% | Oct 2, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $40 | Buy | Initiates | $40 | +145.70% | Sep 9, 2026 |
| BMO Capital | BMO Capital | Buy Initiates $37 | Buy | Initiates | $37 | +127.27% | Aug 18, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $34 | Buy | Maintains | $34 | +108.85% | Aug 14, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $33 | Buy | Reiterates | $33 | +102.70% | Aug 14, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 14, 2026 |
| Raymond James | Raymond James | Buy Initiates $40 | Buy | Initiates | $40 | +145.70% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $35 | Buy | Reiterates | $35 | +114.99% | Jun 2, 2026 |